Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MasTec Inc (MTZ) vs Norwegian Cruise Line Holdings Ltd (NCLH) Price & Performance

MasTec IncTrade
Norwegian Cruise Line Holdings LtdTrade

Price performance (Past 24H)

Key statistics

MasTec Inc vs Norwegian Cruise Line Holdings Ltd — how do they compare? MasTec Inc trades at $350.55 (market cap $26.60B), while Norwegian Cruise Line Holdings Ltd trades at $19.47 (market cap $8.95B). The key difference: MasTec Inc is far larger — about 3× Norwegian Cruise Line Holdings Ltd's market cap, and MasTec Inc is trading nearer its 52-week high, Norwegian Cruise Line Holdings Ltd nearer its low. Which is the better fit depends on your goals.

MTZNCLH
Market Cap
$26.60B$8.95B
Sector
TechnologyConsumer Cyclical
52-Week High
$437.51$26.94
52-Week Low
$172.51$14.79
Enterprise Value
$29.34B$23.92B

Returns comparison

Trailing returns across standard periods

About MasTec Inc

MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.

Read more on MTZ

About Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.

Read more on NCLH